We keep being told to "follow the science" - so, let us do just that.
COVID-19 vaccines
Here is a list of over 1,000 studies on the risks associated with covid vaccination
The Journal of Physical Chemistry: "Mechanisms of SARS-CoV‑2 Evolution Revealing Vaccine-Resistant Mutations in Europe and America"
The importance of understanding SARS-CoV-2 evolution cannot be overlooked. Recent studies confirm that natural selection is the dominating mechanism of SARS-CoV-2 evolution, which favors mutations that strengthen viral infectivity.
Here, we demonstrate that vaccine-breakthrough or antibody-resistant mutations provide a new mechanism of viral evolution.
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
Asymptomatic spread
Nature: "Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China"
The asymptomatic positive rates were 0.321 (95% CI 0.282–0.364)/10,000 and 0.243 (95% CI 0.183–0.315)/10,000, respectively.
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
JAMA: "Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis"
Household secondary attack rates were increased from symptomatic index cases (18.0%; 95% CI, 14.2%-22.1%) than from asymptomatic index cases (0.7%; 95% CI, 0%-4.9%)
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
Immunity
Nature: "SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls"
patients who recovered from SARS possess long-lasting memory T cells that are reactive to SARS-CoV 17 years after the outbreak; these T cells displayed robust cross-reactivity to SARS-CoV-2
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
Cell: "Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals"
Importantly, we detected SARS-CoV-2-reactive T cells in ∼40%–60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating “common cold” coronaviruses and SARS-CoV-2
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
JCI Insight: "A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2"
more than 90% of uninfected adults showed antibody reactivity against SARS-CoV-2. This was evenly distributed across age and sex, correlated with circulating coronaviruses reactivity
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
Brownstone Institute: "146 Research Studies Affirm Naturally Acquired Immunity to Covid-19: Documented, Linked, and Quoted"
The Brownstone Institute previously documented 30 studies on natural immunity as it relates to Covid-19.
This follow-up chart is the most updated and comprehensive library list of 146 of the highest-quality, complete, most robust scientific studies and evidence reports/position statements on natural immunity as compared to the COVID-19 vaccine-induced immunity and allow you to draw your own conclusion.
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
New England Journal of Medicine: "Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2"
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provides natural immunity against reinfection. Recent studies have shown waning of the immunity provided by the BNT162b2 vaccine
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
Mortality rates
New England Journal of Medicine: "Navigating the Uncharted"
the overall clinical consequences of Covid-19 may ultimately be more akin to those of a severe seasonal influenza (which has a case fatality rate of approximately 0.1%) or a pandemic influenza (similar to those in 1957 and 1968) rather than a disease similar to SARS or MERS, which have had case fatality rates of 9 to 10% and 36%, respectively
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
World Health Organization: "Infection fatality rate of COVID-19 inferred from seroprevalence data"
In people younger than 70 years, infection fatality rates ranged from 0.00% to 0.31% with crude and corrected medians of 0.05%
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
Treatments
c19early.com: "COVID-19 early treatment: real-time analysis of 1,352 studies"
Analysis of 34 COVID-19 early treatments, and database of 429 other potential treatments. 67 countries have approved early treatments. Treatments do not replace vaccines and other measures. All practical, effective, and safe means should be used. Elimination is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all variants. Denying efficacy increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage.Recently added: Vitamin D
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
Harms of mandates
Brown University: "Impact of the COVID-19 Pandemic on Early Child Cognitive Development: Initial Findings in a Longitudinal Observational Study of Child Health"
Children born during the pandemic score markedly lower on standard measures of verbal, motor, and overall cognitive ability
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
The Lancet: "Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study"
Our least severe scenario (coverage reductions of 9·8–18·5% and wasting increase of 10%) over 6 months would result in 253 500 additional child deaths and 12 200 additional maternal deaths. Our most severe scenario (coverage reductions of 39·3–51·9% and wasting increase of 50%) over 6 months would result in 1 157 000 additional child deaths and 56 700 additional maternal deaths. These additional deaths would represent an increase of 9·8–44·7% in under-5 child deaths per month, and an 8·3–38·6% increase in maternal deaths per month, across the 118 countries
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]
The Lancet: "Child malnutrition and COVID-19: the time to act is now"
The COVID-19 pandemic is undermining nutrition across the world, particularly in low-income and middle-income countries (LMICs). The worst consequences are borne by young children. Some of the strategies to respond to COVID-19—including physical distancing, school closures, trade restrictions, and country lockdowns—are impacting food systems by disrupting the production, transportation, and sale of nutritious, fresh, and affordable foods, forcing millions of families to rely on nutrient-poor alternatives.
[ Original source | Archive 1 | Archive 2 | Archive 3 | Archive 4 ]